-
OPNT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Opiant Pharmaceuticals (OPNT)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 35.38 mm | 35.38 mm | 35.38 mm | 35.38 mm | 35.38 mm | 35.38 mm |
Cash burn (monthly) | 1.60 mm | (no burn) | 3.30 mm | 2.71 mm | 1.58 mm | 1.29 mm |
Cash used (since last report) | 46.48 mm | n/a | 95.99 mm | 78.78 mm | 45.92 mm | 37.46 mm |
Cash remaining | -11.10 mm | n/a | -60.61 mm | -43.40 mm | -10.55 mm | -2.08 mm |
Runway (months of cash) | -6.9 | n/a | -18.4 | -16.0 | -6.7 | -1.6 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 104.00 k |
Total shares | 13.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Radoff Bradley Louis | 13.00 k | $104.00 k |
Proequities | 0.00 | $0.00 |